David A. Siegel Veru Inc. Transaction History

Two Sigma Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.37 - $0.72 $407 - $792	-1,100 Reduced 9.09%	11,000 $7,000
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.17 $8,107 - $14,157	12,100 New	12,100 $8,000
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $288,925 - $407,035	-63,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $357,523 - $590,611	-60,700 Reduced 48.87%	63,500 $374,000
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $380,358 - $554,829	56,100 Added 82.38%	124,200 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $493,044 - $762,720	68,100 New	68,100 $550,000
Q4 2020 Feb 16, 2021	SELL	$2.36 - $9.99 $306,092 - $1.3 Million	-129,700 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.58 - $3.36 $11,610 - $15,120	-4,500 Reduced 3.35%	129,700 $340,000
Q2 2020 Aug 14, 2020	BUY	$3.01 - $4.02 $215,214 - $287,429	71,500 Added 114.04%	134,200 $448,000
Q1 2020 May 15, 2020	BUY	$2.58 - $4.58 $161,766 - $287,166	62,700 New	62,700 $205,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.